These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7786522)

  • 1. Inhibitor of the release of mast cell mediators does not improve the psoriatic plaque.
    van de Kerkhof PC; Goos M; Christophers E; Baudin M; Dupuy P
    Skin Pharmacol; 1995; 8(1-2):25-9. PubMed ID: 7786522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tiacrilast, a potent mast cell degranulation inhibitor, does not improve adult atopic eczema.
    Czarnetzki BM; Brechtel B; Braun-Falco O; Christophers E; Schöpf E; Reckers-Czaschka R; Baudin M; Dupuy P
    Dermatology; 1993; 187(2):112-4. PubMed ID: 8102913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study.
    Pestelli E; Caproni M; Giomi B; Volpi W; Spallanzani A; Cardinali C; Floriani I; Fabbri P
    Int J Tissue React; 2001; 23(3):97-103. PubMed ID: 11517856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tiacrilast, a mast cell mediator-release inhibitor, on murine experimental contact dermatitis.
    Csatò M; Judák R; Bozóky B; Czarnetzki BM
    Skin Pharmacol; 1990; 3(3):164-70. PubMed ID: 1981832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
    Brody I
    Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans.
    Leonardi A; Abelson MB
    Clin Ther; 2003 Oct; 25(10):2539-52. PubMed ID: 14667955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.
    Fischer M; Harvima IT; Carvalho RF; Möller C; Naukkarinen A; Enblad G; Nilsson G
    J Clin Invest; 2006 Oct; 116(10):2748-56. PubMed ID: 16964309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the degranulation and histamine release of purified rat peritoneal mast cells. The inhibitory effect of histamine and other chemicals].
    Hirano H
    Nihon Ika Daigaku Zasshi; 1989 Aug; 56(4):392-9. PubMed ID: 2478572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell degranulation in hemorrhagic shock in rats and the effects of vasoactive intestinal peptide, aprotinin and H1 and H2-receptor blockers on degranulation.
    Tikiz H; Tunçel N; Gürer F; Baycu C
    Pharmacology; 1991; 43(1):47-52. PubMed ID: 1720560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases.
    Singh J; Shah R; Singh D
    Int Immunopharmacol; 2016 Nov; 40():362-384. PubMed ID: 27694038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects on sympathetic neurotransmission of mast cell degranulation by compound 48/80 or antigen in the rat isolated perfused heart.
    Ries P; Fuder H
    Methods Find Exp Clin Pharmacol; 1994; 16(6):419-35. PubMed ID: 7530791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
    J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
    Ohta Y; Kobayashi T; Ishiguro I
    Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O
    Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
    Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary mastocytoma treated with tranilast.
    Katoh N; Hirano S; Yasuno H
    J Dermatol; 1996 May; 23(5):335-9. PubMed ID: 8675824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation.
    Dimitriadou V; Pang X; Theoharides TC
    Int J Immunopharmacol; 2000 Sep; 22(9):673-84. PubMed ID: 10884588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
    Vahlquist A; Törmä H; Carlsson B
    Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
    Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
    Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.